Evidence map›Paper›PMID 28985759›Full record

ArticleJournal of neuroinflammation2017

Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.

Wen Fu, Vlatka Vukojevic, Aarti Patel, Rania Soudy, David MacTavish, David Westaway, Kamaljit Kaur, Valeri Goncharuk, Jack Jhamandas

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Aging · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. FeMolecular neurobiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Wen FuDepartment of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, 530 Heritage Medical Research Centre, Edmonton, AB, T6G 2S2, Canada.
Vlatka VukojevicDepartment of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, 530 Heritage Medical Research Centre, Edmonton, AB, T6G 2S2, Canada.
Aarti PatelDepartment of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, 530 Heritage Medical Research Centre, Edmonton, AB, T6G 2S2, Canada.
Rania SoudyDepartment of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, 530 Heritage Medical Research Centre, Edmonton, AB, T6G 2S2, Canada.
David MacTavishDepartment of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, 530 Heritage Medical Research Centre, Edmonton, AB, T6G 2S2, Canada.
David WestawayDepartment of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, 530 Heritage Medical Research Centre, Edmonton, AB, T6G 2S2, Canada.
Kamaljit KaurChapman University School of Pharmacy, Irvine, CA, USA.
Valeri GoncharukRussian Cardiology Research Center, Moscow, Russia.
Jack JhamandasDepartment of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, 530 Heritage Medical Research Centre, Edmonton, AB, T6G 2S2, Canada. jack.jhamandas@ualberta.ca.
University of Alberta · CAWomen and Children’s Health Research Institute · CAChapman University · USInstitute of Experimental Cardiology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuroinflammation in the brain consequent to activation of microglia is viewed as an important component of Alzheimer's disease (AD) pathology. Amyloid beta (Aβ) protein is known to activate microglia and unleash an inflammatory cascade that eventually results in neuronal dysfunction and death. In this study, we sought to identify the presence of amylin receptors on human fetal and murine microglia and determine whether Aβ activation of the inflammasome complex and subsequent release of cytokines is mediated through these receptors.

methodsThe presence of dimeric components of the amylin receptor (calcitonin receptor and receptor activity modifying protein 3) were first immunohistochemically identified on microglia. Purified human fetal microglial (HFM) cultures were incubated with an in vivo microglial marker, DyLight 594-conjugated tomato lectin, and loaded with the membrane-permeant green fluorescent dye, Fluo-8L-AM for measurements of intracellular calcium [Ca

resultsAcute applications of human amylin or Aβ

conclusionMicroglial amylin receptors mediate Aβ-evoked inflammation, and amylin receptor antagonists therefore offer an attractive therapeutic target for intervention in AD.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsCaspase 1Cell Line, TransformedCells, CulturedCyclic AMPCytokinesFemaleFetusGene Expression RegulationHumansInflammationLipopolysaccharidesMaleMiceAmyloid beta-Peptidesamyloid beta-protein (1-42)Caspase 1Cyclic AMPCytokinesLipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 ProteinPeptide FragmentsPeptides, CyclicReceptors, Islet Amyloid PolypeptideAC253 peptideAlzheimer’s diseaseAmylin receptorCaspase-1CytokinesInflammasomeMicrogliaNLRP3β-amyloid

Identifiers

PMID28985759
PMCPMC5639602
OpenAlexW2764061934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.